bioSyntagma Company

A precision medicine company with novel technology enabling advanced diagnostics and biomarker discovery
Technology: Diagnostic
Industry: Biomarkers
Headquarters: Others
Employees Number: 1-10
Investors Number: 2
Total Funding: $1.2M
Estimated Revenue: Less than $1M
Last Funding Type: Grant

Visit Website
info@biosyntagma.com
Register and Claim Ownership